(Q53228620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Enzo Ballatori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Fausto Roila

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Benedetta Ruggeri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Maura Betti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Samanta Sarti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Giancarla Soru

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Giorgio Cruciani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Biffi Andrea

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Robert R Deuson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

29 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

179-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16941136%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00520-006-0109-7

29 December 2019

exact match

0 references

cites work

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-006-0109-7

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-006-0109-7

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference

21 January 2018

1 reference

12 December 2020

Anticipatory nausea and vomiting.

1 reference

12 December 2020

Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research

1 reference

12 December 2020

Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research

1 reference

12 December 2020

Quality of life consequences of chemotherapy-induced emesis

1 reference

12 December 2020

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

Economics and health-related quality of life in antiemetic therapy: recommendations for trial design

1 reference

12 December 2020

Incidence of chemotherapy-induced nausea and emesis after modern antiemetics

1 reference

12 December 2020

Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study

1 reference

12 December 2020

Delayed emesis: incidence, pattern, prognostic factors and optimal treatment

1 reference

12 December 2020

Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

1 reference

12 December 2020

Patient compliance with quality of life questionnaires. Italian Group for Evaluation of Outcomes in Oncology (I.G.E.O.).

1 reference

12 December 2020

Unsolved problems in evaluating the quality of life of cancer patients

1 reference

12 December 2020

Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy

1 reference

12 December 2020

Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis. Italian Group of Antiemetic Research

1 reference

12 December 2020

Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall

1 reference

12 December 2020

Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.

1 reference

12 December 2020

Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy

1 reference

12 December 2020

Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.

1 reference

12 December 2020

Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer

1 reference

12 December 2020

Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)

1 reference

12 December 2020

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.

1 reference

12 December 2020